Where can I find the specific financial results for CVS Health's first quarter of 2025?

The specific financial results for the three months ended March 31, 2025, are detailed in the press release furnished as Exhibit 99.1 to the 8-K filing dated May 1, 2025.

What key financial metrics should I look for in the press release?

Investors should look for key metrics such as revenue, earnings per share (EPS), net income, and any updated financial guidance or outlook provided by CVS Health for the remainder of 2025.

Is the information in this 8-K filing the same as if it were 'filed'?

No, the information in this Current Report on Form 8-K, including the furnished press release, is generally not deemed 'filed' for purposes of Section 18 of the Exchange Act or incorporated by reference into other filings unless expressly stated. This means it may not carry the same legal implications as a formally filed document.

When was the event date associated with this filing?

The event date associated with this filing, referring to the announcement or release of the information, was April 30, 2025.

CVS 8-K: Earnings & Results

Summary

CVS Health Corporation filed an 8-K on May 1, 2025, to report its financial results for the first quarter ended March 31, 2025. The report primarily serves to furnish a press release detailing these results, which was issued on the same day. Investors should refer to the furnished press release (Exhibit 99.1) for specific financial performance metrics, including revenue, earnings per share, and any forward-looking guidance provided by the company. While this 8-K filing itself does not contain the detailed financial data, it formally incorporates the press release, making it the primary source of information for understanding CVS Health's recent operational and financial condition. Investors are advised to review Exhibit 99.1 for a comprehensive overview of the company's Q1 2025 performance and any strategic updates or outlook shared by management.

Key Highlights

1CVS Health announced its first-quarter 2025 financial results on May 1, 2025.
2The results were disclosed via a press release furnished as part of an 8-K filing.
3The reporting period covers the three months ended March 31, 2025.
4Exhibit 99.1 of the 8-K contains the full press release with detailed financial information.
5The information furnished is not deemed 'filed' for purposes of certain securities laws unless specifically incorporated by reference.
6Investors need to consult the press release (Exhibit 99.1) for performance details and company outlook.

CVS HEALTH Corp 8-K Report, Financial Results (May 1, 2025)

Summary

Key Highlights

Frequently Asked Questions